June 2017





Dialogues in Dialysis Access

By Bart Dolmatch, MD, FSIR


Updated KDOQI Guidelines on Vascular Access: What to Expect

A brief summary of some of the changes in hemodialysis access over the past decade and what can be expected in the upcoming KDOQI guidelines.

By Charmaine E. Lok, MD, MSc, FRCP(C)

Economics and the Next Decade of Dialysis Access Intervention

A brief perspective on how health care economics will affect dialysis access in the United States.

By Prabir Roy-Chaudhury, MD, PhD

Ask the Experts: Where Do You See Percutaneous Arteriovenous Fistula Creation Fitting Into Practices in the Next Several Years?

Experts offer their outlook for the future of percutaneous arteriovenous fistula access creation.

With Sanford Altman, MD; Eric K. Peden, MD; Mark Turco, MD; and James F. McGuckin, Jr, MD

Ten Lessons Learned in Peritoneal Dialysis

Expert observations aimed at improving quality of care and outcomes related to the use of peritoneal dialysis catheters.

By Peter B. Hathaway, MD

Ask the Experts: What Outcomes Will Foster or Stymie Adoption of Drug-Coated Balloons in AV Fistula Intervention?

Experts discuss how patency, cost-effectiveness, and reimbursement may impact if and when DCBs are used.

With Scott O. Trerotola, MD; Kate Steiner, BSc, MBBS, MRCP, FRCR; Andrew Holden, MBChB, FRANZCR, EBIR; and Prabir Roy-Chaudhury, MD, PhD

Training the Next Generation of AV Access Specialists: Necessary Skills, Expertise, and Settings

Dr. Davidson provides his perspective on the dialysis access education landscape.

With Ingemar Davidson, MD, PhD, FACS


Sponsored by AV Medical Technologies Inc.

Introducing Chameleon™: The Next Generation of PTA Balloons

PTA and injection. Combined.

With Jeffrey G. Hoggard, MD; John A. Kaufman, MD; and John R. Ross, MD


Sponsored by Philips Volcano

Office-Based Lab Models: Business Operations and Growth Strategies

The third in a four-part series discussing office-based labs (OBLs) and ambulatory surgery centers (ASCs) from the perspective of three physicians. This article explores the business operations in an OBL and ASC environment and strategies how to grow the business. Previous articles included OBL development, key issues and lessons learned, and a clinical overview of therapies and devices in the OBL. The final article will focus on trends and predictions for the OBL future.

With Donald S. Cross, MD, FACC; Alberto Gonzalez, MD, FACS; and Kenneth J. Wright, MD, FACS
Sponsored by Philips Volcano

The Value of Intravascular Ultrasound Use in Hemodialysis Arteriovenous Access

A panel of experts addresses how and why clinicians today are increasingly reaching for IVUS during AV access evaluations.

With Bart Dolmatch, MD; Rick de Graaf, MD, PhD; Jeffrey E. Hull, MD; and Edward Pavillard, MD


New 2017 CPT Codes for Dialysis Access Maintenance and Intervention

A review of the new codes, new definitions, general instructions for the code set, and nuances of the new codes as illustrated by coding scenarios.

By Katharine L. Krol, MD, FSIR, FACR


MIIPs: Minimally Invasive, Cost-Effective Care

Founders of the Interventional Initiative discuss the goals and challenges of the organization and how they are attempting to bring MIIPs to the forefront of the health care system.

With Isabel Newton, MD, PhD; and Susan Jackson, MBA, RT(R)(CV)



An Interview With Wei Zhou, MD, FACS

Dr. Zhou offers insights on a variety of vascular topics, including the use of a brain structural connectivity graph for treatment selection and the impact of embolic infarct volume on cognitive changes.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.